Home / Contract Awards / FDA Selects Four Firms to Develop Automated Biological Product Reporting Methods

FDA Selects Four Firms to Develop Automated Biological Product Reporting Methods

The Food and Drug Administration has awarded four companies contracts worth up to $75M each to develop automated methods for reporting adverse drug events.

IBM (NYSE: IBM), Acumen, Dovel Technologies and IQVIA Government Solutions will use artificial intelligence, machine learning, natural language processing and other automation techniques to create data collection and analysis systems for the FDA’s Center for Biologics Evaluation and Research, the agency said Thursday in a FedBizOpps notice.

FDA requires each contractor to offer indirect access to medical information of U.S. patients, including administrative and claims data and electronic health records.

The indefinite delivery/indefinite quantity contracts have a five-year ordering period.

The agency also selected the four companies to develop surveillance tools as part of the Biologics Effectiveness and Safety Initiative.

Check Also

AECOM JV Wins $95M NAVFAC Architectural, Engineering Contract

A joint venture comprised of AECOM (NYSE: ACM), Baker and Cardno has won a potential five-year, $95M contract from Naval Facilities Engineering Command Atlantic to help plan multiple projects on the East Coast and international locations.

John Heller

John Heller: PAE to Provide Aircraft Maintenance Support at Eglin AF Base

PAE will help the U.S. Air Force's 96th Test Wing maintain aircraft and equipment at Eglin AF Base in Florida under a contract worth potentially $158M over seven and a half years. “PAE employs top aviation industry professionals who will lend their expertise to a full range of maintenance capabilities at Eglin,” said John Heller, president and CEO of PAE and a 2020 Wash100 awardee.